🇺🇸 FDA
Pipeline program

PLACEBO, Nicetile 500 mg polvere per soluzione orale

Phase 3 small_molecule active

Quick answer

PLACEBO, Nicetile 500 mg polvere per soluzione orale for amyotrophic lateral sclerosis is a Phase 3 program (small_molecule) at Istituto Gentili S.r.l. with 1 ClinicalTrials.gov record(s).

Program details

Company
Istituto Gentili S.r.l.
Indication
amyotrophic lateral sclerosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials